Evidence map›Paper›PMID 39032726›Full record

ArticleBiological psychiatry2025

Robust Brain Correlates of Cognitive Performance in Psychosis and Its Prodrome.

Heather Burrell Ward, Adam Beermann, Jing Xie, Gulcan Yildiz, Karlos Manzanarez Felix, Jean Addington, Carrie E Bearden, Kristin Cadenhead, Tyrone D Cannon, Barbara Cornblatt and 18 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Neural and Behavioral Markers of Negative Symptoms and Cognitive Impairment in Patients with Psychosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Heather Burrell WardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: heather.b.ward@vumc.org.
Adam BeermannDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Jing XieDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Gulcan YildizDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Karlos Manzanarez FelixDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Jean AddingtonDepartment of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
Carrie E BeardenSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Behavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, California.
Kristin CadenheadDepartment of Psychiatry, University of California, San Diego, La Jolla, California.
Tyrone D CannonDepartment of Psychology and Psychiatry, Yale University, New Haven, Connecticut.
Barbara CornblattDepartment of Psychiatry, Zucker Hillside Hospital and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Glen Oaks, New York.
Matcheri KeshavanDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Daniel MathalonDepartment of Psychiatry, University of California, San Francisco, San Francisco, California.
Diana O PerkinsDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Larry SeidmanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
William S StoneDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Ming T TsuangDepartment of Psychiatry, University of California, San Diego, La Jolla, California.
Elaine F WalkerDepartment of Psychology, Emory University, Atlanta, Georgia.
Scott WoodsDepartment of Psychiatry, Yale University, New Haven, Connecticut.
Michael J ColemanDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Sylvain BouixDepartment of Software Engineering and Information Technology, École de technologie supérieure, Montréal, Québec, Canada.
Daphne J HoltDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Dost ÖngürMcLean Hospital and Harvard Medical School, Boston, Massachusetts.
Alan BreierDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana.
Martha E ShentonDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Stephan HeckersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Mark A HalkoMcLean Hospital and Harvard Medical School, Boston, Massachusetts.
Kathryn E LewandowskiMcLean Hospital and Harvard Medical School, Boston, Massachusetts.
Roscoe O BradyDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; McLean Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: robrady@bidmc.harvard.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
STRESS AND EMOTIONAL REACTIVITYP50MH066286 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YEE-BRADBURY, CINDY M. · 2003 to 2014
$18.6M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lea K Davis · 2020 to 2026
$10.3M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
Academic-Community EPINET (AC-EPINET): Mitigating Barriers to CareR01MH120588 · NIMH · INDIANA UNIVERSITY INDIANAPOLIS · PI BREIER, ALAN · 2020 to 2023
$5.8M
Human Connectome Project for Early PsychosisU01MH109977 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BREIER, ALAN, SHENTON, MARTHA E. · 2016 to 2020
$5.5M
Network Mediation of Experiential and Expressive Deficits in Psychotic DisordersR01MH116170 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Roscoe O. Brady, KATHRYN Eve LEWANDOWSKI · 2019 to 2026
$5.4M
2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
NCATS NIH HHS KL2 TR002245NCATS NIH HHS UL1 TR001863NICHD NIH HHS P50 HD103537NIDA NIH HHS K23 DA059690NIMH NIH HHS P50 MH066286NIMH NIH HHS R01 MH076989NIMH NIH HHS R01 MH111448NIMH NIH HHS R01 MH116170NIMH NIH HHS R01 MH117012NIMH NIH HHS R01 MH120588NIMH NIH HHS U01 MH066069NIMH NIH HHS U01 MH066134NIMH NIH HHS U01 MH081857NIMH NIH HHS U01 MH081902NIMH NIH HHS U01 MH081928NIMH NIH HHS U01 MH081944NIMH NIH HHS U01 MH081988NIMH NIH HHS U01 MH082022NIMH NIH HHS U01 MH109977
6 · The paper itself

Abstract

backgroundNeurocognitive impairment is a well-known phenomenon in schizophrenia that begins prior to psychosis onset. Connectome-wide association studies have inconsistently linked cognitive performance to resting-state functional magnetic resonance imaging. We hypothesized that a carefully selected cognitive instrument and refined population would allow identification of reliable brain-behavior associations with connectome-wide association studies. To test this hypothesis, we first identified brain-cognition correlations via a connectome-wide association study in early psychosis. We then asked, in an independent dataset, if these brain-cognition relationships would generalize to individuals who develop psychosis in the future.

methodsThe Seidman Auditory Continuous Performance Task (ACPT) effectively differentiates healthy participants from those with psychosis. Our connectome-wide association study used the HCP-EP (Human Connectome Project for Early Psychosis) (n = 183) to identify links between connectivity and ACPT performance. We then analyzed data from the NAPLS2 (North American Prodrome Longitudinal Study 2) (n = 345), a multisite prospective study of individuals at risk for psychosis. We tested the connectome-wide association study-identified cognition-connectivity relationship in both individuals at risk for psychosis and control participants.

resultsOur connectome-wide association study in early-course psychosis identified robust associations between better ACPT performance and higher prefrontal-somatomotor connectivity (p < .005). Prefrontal-somatomotor connectivity was also related to ACPT performance in at-risk individuals who would develop psychosis (n = 17). This finding was not observed in nonconverters (n = 196) or control participants (n = 132).

conclusionsThis connectome-wide association study identified reproducible links between connectivity and cognition in separate samples of individuals with psychosis and at-risk individuals who would later develop psychosis. A carefully selected task and population improves the ability of connectome-wide association studies to identify reliable brain-phenotype relationships.

Indexed as

BrainConnectomeMagnetic Resonance ImagingPsychotic DisordersAdolescentAdultCognitionCognitive DysfunctionFemaleHumansLongitudinal StudiesMaleNeuropsychological TestsProdromal SymptomsYoung AdultAuditoryClinical high riskCognitive performanceEarly psychosisPsychosisResting-state fMRI

Identifiers

PMID39032726
PMCPMC11634655

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.